| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.0094 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |